740867 SE Klinisches Prüfpräperat (Investigational Medicinal Product, IMP) - Dossier

Sommersemester 2026 | Stand: 16.12.2025 LV auf Merkliste setzen
Institut für Pharmazie Institut für Pharmazie
Dr. Stephan Reitinger Dr. Stephan Reitinger
740867
SE Klinisches Prüfpräperat (Investigational Medicinal Product, IMP) - Dossier
SE 1
1
Block
jährlich
Englisch

•    Students should understand the content and structure of an IMPD and its role in the development process
•    They should be capable of placing information in the relevant sections

•    Structure of the IMPD
•    IMPD content reflecting the developmental stage
•    From IMPD to Marketing Authorization Dossier Module 3
•    Current requirements according to the CTR (CTIS)
•    Practical example of writing an IMPD

seminar applying theoretic knowledge to specific practical situations

active participation in seminar demonstrating understanding of theoretical principles and critical reasoning

Modules 1 and 2

30.04.2024
Gruppe 0
Termine dieser Gruppe als iCalendar (.ics) exportieren
Hilfe
Datum Uhrzeit Ort
Mo 20.04.2026
 13.30 - 17.00 L.03.112 L.03.112
Di 21.04.2026
 14.00 - 17.30 L.03.112 L.03.112
Di 28.04.2026
 14.00 - 17.30 L.03.112 L.03.112
Gruppe Anmeldefrist
01.02.2026 00:00 - 21.02.2026 23:59
Reitinger S.